ACUITY PHARMACEUTICALS
Dead / Abandoned — Abandoned — no statement of use filed (as of 14 Jan 2019)
What this means for you
This application is over — abandoned 14 Jan 2019. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87791663
- Mark type
- Stylized text
- Filed
- 09 Feb 2018
- Published for opposition
- 17 Apr 2018
- Abandoned
- 14 Jan 2019
- Attorney of record
- Jenevieve Maerker, Esq.
Goods and services
- Class 005 — Pharmaceuticals: House mark used for drug delivery agents consisting of polymer compounds that facilitate the delivery of pharmaceuticals for the treatment of diseases and conditions, including ocular diseases, namely, uveitis, retinal vein occlusion, macular edema, macular disease, retinal disease, and glaucoma and diseases and conditions in joints, namely, osteoarthritis, bursitis, fibrotic diseases, and infections
- Class 010 — Medical apparatus: House mark for sustained drug delivery systems for pharmaceuticals
Owner
- EYEPOINT PHARMACEUTICALS US, INC., WATERTOWN, MA, US
- pSivida US, Inc., Watertown, MA, US
- pSivida US, Inc., Watertown, MA, US
Prosecution history
- 14 Jan 2019 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 14 Jan 2019 — ABANDONMENT - NO USE STATEMENT FILED
- 12 Jun 2018 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 18 Apr 2018 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 18 Apr 2018 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 18 Apr 2018 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 17 Apr 2018 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Apr 2018 — PUBLISHED FOR OPPOSITION
- 28 Mar 2018 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 08 Mar 2018 — ASSIGNED TO LIE
- 28 Feb 2018 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 28 Feb 2018 — EXAMINER'S AMENDMENT ENTERED
- 28 Feb 2018 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 28 Feb 2018 — EXAMINERS AMENDMENT E-MAILED
- 28 Feb 2018 — EXAMINERS AMENDMENT -WRITTEN